AbbVie Inc.
MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF
Last updated:
Abstract:
The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment, and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
Status:
Application
Type:
Utility
Filling date:
22 Feb 2021
Issue date:
20 Jan 2022